Last close · 16 Oct 2026
Rs 61.66 -0.61%
Financials
Citi Pharma Ltd. (CPHL) financials
7 years of annual results (FY2020 – FY2026), 20 quarters.
Citi Pharma Ltd. (CPHL) reported revenue of Rs 14.1 bn for FY2026 (Jul 2025 – Jun 2026), up 7.0% from FY2025.
Profit attributable to shareholders was Rs 790.3 mn (EPS Rs 3.46), down 11.4%, a net margin of 5.6%.
No cash dividend was declared for FY2026.
Net debt stood at Rs 2.8 bn.
Return on equity was 7.3%.
Over the last five years revenue grew at a compound 19.4% a year.
At Rs 61.66 (close on 16 Oct 2026) the shares trade at 17.8× earnings (FY2026) and 1.30× book value.
Fundamentals
CPHL at a glance
Revenue · FY2026
Rs 14.1 bn
▲ 7.0% year on year
Profit attributable to shareholders · FY2026
Rs 790.3 mn
▼ 11.4% year on year
EPS – basic (Rs) · FY2026
Rs 3.46
▼ 11.4% year on year
Dividend per share (Rs) · FY2026
Rs 0.00
▼ 100.0% year on year
Net margin · FY2026
5.6%
-1.2 pts year on year
Debt to equity · FY2026
28.6%
+1.5 pts year on year
Financial statements
Income statement
Revenue, costs, profit and earnings per share.
- Revenue · FY2026
- Rs 14.1 bn
- Profit attributable · FY2026
- Rs 790.3 mn
Balance sheet
Assets, liabilities, debt and shareholders' equity.
- Total assets · FY2026
- Rs 18.3 bn
- Equity · FY2026
- Rs 10.8 bn
Financial highlights
CPHL financial results
| Rs bn | FY2026 Jul 2025 – Jun 2026 | FY2025 Jul 2024 – Jun 2025 | FY2024 Jul 2023 – Jun 2024 | FY2023 Jul 2022 – Jun 2023 | FY2022 Jul 2021 – Jun 2022 | FY2021 Jul 2020 – Jun 2021 | FY2020 Jul 2019 – Jun 2020 |
|---|---|---|---|---|---|---|---|
| Revenue | 14.1 | 13.2 | 12.4 | 12.4 | 9.8 | 5.8 | 3.5 |
| Gross profit | 2.5 | 2.0 | 1.6 | 1.5 | 1.4 | 0.8 | 0.4 |
| Operating profit | 1.9 | 1.6 | 1.2 | 1.2 | 1.0 | 0.6 | 0.3 |
| Profit after tax | 0.8 | 0.9 | 0.8 | 0.7 | 0.7 | 0.4 | 0.1 |
| Profit attributable to shareholders | 0.8 | 0.9 | 0.8 | 0.7 | 0.7 | 0.4 | 0.1 |
| EPS – basic (Rs) Rs | 3.46 | 3.90 | 3.65 | 2.88 | 2.88 | 4.22 | 28.97 |
| Dividend per share (Rs) Rs | 0.00 | 3.50 | 3.25 | 2.50 | 0.00 | 0.00 | 0.00 |
| Total assets | 18.3 | 18.4 | 11.4 | 10.0 | 8.1 | 6.5 | 2.5 |
| Total equity | 10.8 | 10.9 | 5.6 | 5.4 | 4.7 | 4.4 | 1.0 |
| Total debt | 3.1 | 2.9 | 1.5 | 1.8 | 0.9 | 0.7 | 0.5 |
| Net cash from operating activities | 0.2 | (0.3) | 1.3 | (0.3) | (0.3) | 0.7 | 0.1 |
| Capital expenditure | (0.7) | (0.2) | (0.6) | (1.0) | (0.6) | (0.3) | (0.1) |
| Free cash flow (operating cash flow − capex) | (0.5) | (0.5) | 0.8 | (1.3) | (0.9) | 0.5 | (0.0) |
| Rs bn | TTM to Jun 2026 | Q4 FY2026 Apr – Jun 2026 | Q3 FY2026 Jan – Mar 2026 | Q2 FY2026 Oct – Dec 2025 | Q1 FY2026 Jul – Sep 2025 | Q4 FY2025 Apr – Jun 2025 | Q3 FY2025 Jan – Mar 2025 | Q2 FY2025 Oct – Dec 2024 | Q1 FY2025 Jul – Sep 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 14.1 | 3.3 | 3.1 | 4.3 | 3.4 | 3.1 | 3.3 | 3.5 | 3.2 |
| Gross profit | 2.5 | 0.5 | 0.5 | 1.0 | 0.5 | 0.6 | 0.5 | 0.5 | 0.4 |
| Operating profit | 1.9 | 0.3 | 0.4 | 0.8 | 0.4 | 0.4 | 0.4 | 0.4 | 0.3 |
| Profit after tax | 0.8 | (0.1) | 0.3 | 0.4 | 0.2 | 0.2 | 0.2 | 0.3 | 0.2 |
| Profit attributable to shareholders | 0.8 | (0.1) | 0.3 | 0.4 | 0.2 | 0.2 | 0.2 | 0.3 | 0.2 |
| EPS – basic (Rs) Rs | 3.46 | (0.41) | 1.21 | 1.77 | 0.89 | 0.93 | 0.96 | 1.12 | 0.88 |
| Dividend per share (Rs) Rs | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 3.50 | 0.00 | 0.00 | 0.00 |
| Total assets | 18.3 | 18.3 | 18.9 | 20.9 | 17.9 | 18.4 | 13.6 | 12.6 | 12.2 |
| Total equity | 10.8 | 10.8 | 11.0 | 10.7 | 11.1 | 10.9 | 5.6 | 5.3 | 5.8 |
| Total debt | 3.1 | 3.1 | 3.6 | 5.7 | 2.8 | 2.9 | 2.9 | 1.8 | 1.5 |
| Net cash from operating activities | 0.2 | 1.1 | (0.7) | 0.2 | (0.5) | 0.3 | (0.9) | 0.4 | (0.1) |
| Capital expenditure | (0.7) | (0.6) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.1) | (0.0) |
| Free cash flow (operating cash flow − capex) | (0.6) | 0.5 | (0.7) | 0.1 | (0.5) | 0.2 | (1.0) | 0.3 | (0.1) |
Figures in Pakistani rupees as reported by the company; costs and cash outflows in brackets. Free cash flow and book value per share are calculated by Smart Money; TTM = the latest four quarters. Updated 16 Oct 2026.